#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thalassaemia beta Oesophageal squamous cell carcinoma stage III Autoimmune disorder Chronic myelomonocytic leukaemia Oesophageal squamous cell carcinoma stage II Infantile apnoea Myotonia Rhabdomyosarcoma recurrent Neuropathy peripheral Spinal muscular atrophy Mitochondrial myopathy Chronic inflammatory demyelinating polyradiculoneuropathy Alveolar rhabdomyosarcoma Malignant oligodendroglioma Adult T-cell lymphoma/leukaemia refractory More trials…

    Learn about Rare Diseases

    Primary hyperoxaluria – Life with Disease Antisynthetase syndrome Anaplastic thyroid cancer – Trials in Disease Leiomyosarcoma metastatic – Life with Disease Pelizaeus-Merzbacher disease – Trials in Disease Basal cell naevus syndrome – Basic Information Familial haemophagocytic lymphohistiocytosis – Trials in Disease Focal segmental glomerulosclerosis – Treatment Congenital hypotransferrinaemia – Life with Disease Usher’s syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Levoleucovorin Obeticholic Acid Msv/As ABIRATERONE DECANOATE Lactulose Rezafungin Acetate Hydroxi-Methionine Calcium GSK5764227 Estradiol Valerate Donidalorsen Iph5201 INSULIN DEGLUDEC Rasburicase MAGNESIUM ACETATE TETRAHYDRATE Olaptesed Pegol PUCOTENLIMAB GSK5458514 Pal1-15 Acetate Poltreg-T1D TRIACYLGLYCEROL LIPASE More therapies…

    Learn about Your Condition

    Colon cancer stage III Malignant fibrous histiocytoma Hypoalbuminaemia Elderly Leukoencephalopathy Meniscus injury Hepatitis alcoholic Neurodegenerative disorder Anaplastic thyroid cancer Eczema Breast cancer recurrent Iron overload Ligament operation Gallbladder cancer Normal pressure hydrocephalus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Niepubliczny Zaklad Opieki Zdrowotnej Biogenes Sp….

Niepubliczny Zaklad Opieki Zdrowotnej Biogenes Sp. z o.o

Pl. Bzowy 1, Wroclaw, 53-224, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects of Upadacitinib for Patients with Active Psoriatic Arthritis and Axial Spondyloarthritis

    Recruiting

    3 1
    Investigated Diseases:
    • Axial spondyloarthritis
    • Psoriatic arthropathy
    Investigated Drugs:
    • Upadacitinib
    Belgium Poland

  • Study on the Effectiveness and Safety of Efgartigimod PH20 SC for Adults with Systemic Sclerosis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Efgartigimod Alfa
    Belgium Bulgaria Croatia Czechia Denmark France +10

  • Study on the Effectiveness and Safety of Deucravacitinib for Adults with Active Sjogren’s Syndrome

    Recruiting

    3 1 1
    Investigated Drugs:
    • Deucravacitinib
    Austria Belgium Bulgaria Finland France Germany +9

  • Study on the Effectiveness and Safety of CT-P13 for Patients with Moderate to Severe Rheumatoid Arthritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Folic Acid
    • HYDROXYCHLOROQUINE
    • Ibuprofen
    Poland

  • Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Active Psoriatic Arthritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Bimekizumab
    Belgium Czechia France Germany Hungary Italy +2

  • Study on the Effectiveness and Safety of Bimekizumab and Risankizumab in Adults with Active Psoriatic Arthritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Bimekizumab
    • Risankizumab
    Bulgaria Czechia Germany Hungary Poland Spain

  • Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Active Axial Spondyloarthritis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Bimekizumab
    Belgium Czechia France Germany Hungary Poland +1

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!